衞寧健康(300253.SZ):2019年淨利預增25%-45%
格隆匯1月22日丨衞寧健康(300253.SZ)披露2019年度業績預告,公司預計2019年1-12月歸屬於上市公司股東的淨利潤為約3.795億元-4.405億元,同比增長約25%-45%。業績變動原因如下:
在國家持續出台行業利好政策的背景下,報告期內,公司持續深化“雙輪驅動”發展戰略,繼續堅持以市場為導向,憑藉專業、成熟、全面的產品和服務持續做大做強主營業務,使得傳統的醫療衞生信息化業務訂單同比快速增長,營業收入同比快速增長,繼續加強在國內同行業中的領先地位。
同時,創新的互聯網+醫療健康業務整體有序推進。其中合併報表範圍內(主要包括子公司衞寧互聯網科技有限公司(衞寧互聯網)及其控股子公司納裏健康科技有限公司(納裏健康))的創新業務中,因建設費大幅增長、第三方支付公司返點費率大幅下調等原因,綜合導致衞寧互聯網(單體)收入同比僅略有增長,且出現虧損;因互聯網醫院業務持續推進、原結算滯後的部分項目進行結算等原因,導致納裏健康收入同比較快增長,且同比有所減虧。此外,上海鑰世圈雲健康科技發展有限公司(鑰世圈)收入同比高速增長,且同比有所減虧;上海金仕達衞寧軟件科技有限公司(衞寧科技)收入同比快速增長,但因承擔國家醫保局等重要項目投入加大等原因,虧損額同比大幅增加,且因此導致整個創新業務板塊虧損額同比大幅增加(按權益計算,其虧損額佔比約為70%)。
預計2019年度總的營業收入同比增長將超過30%。
報告期內,預計非經常性損益對淨利潤的影響金額約為5600萬元(上年同期約為2451.59萬元),主要為政府補助等,歸屬於上市公司股東的扣除非經常性損益的淨利潤同比增長約16%-38%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.